SBC Medical Group Holdings ISBC
13F holders, Q3 2024 (September 30)3holders −2
1new positions
3sold out
$1.59avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding SBC Medical Group Holdings I (SBC) in their 13F filings, down 2 from Q2 2024. 1 opened new positions and 3 sold out. The largest holders were UBS Group AG ($26K), Tuttle Capital Management, LLC ($2K) and Tower Research Capital LLC (TRC) ($167).
- Company
- SBC Medical Group Holdings I
- CUSIP
- 73245B107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $167 |
| Exits | 3 | $1.9M |
All 13F filers, Q2 2024 → Q3 2024: 1,991 shares bought and 143,874 shares sold, net −141,883 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| UBS Group AG | 0.00% | Add +158.9% | 3,210 | $26K |
| Tuttle Capital Management, LLC | 0.01% | No change | 14,369 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 21 | $167 |
"% of holder's portfolio" is SBC's weight in each manager's 13F, not the share of SBC Medical Group Holdings I the manager owns.